Clinical Perspectives

Study Shows Seaweed Sugar (L-fucose) May Trigger Immune Responses That Combat Melanoma

Moffitt researchers discovered that administering oral L-fucose triggers potent antitumor immune responses that suppress tumors and enhance...

Moffitt's Endocrine Oncology Program Multidisciplinary Approach to Cancer Care

Moffitt's Endocrine Oncology Program is comprised of a multispecialty team of oncologists, surgeons, pathologists, and more who collaborate in a...

Health Insurance Literacy Study in Head and Neck Cancer Patients and Caregivers

Moffitt physicians participated in a pilot study monitoring the health insurance literacy levels of head & neck cancer patients and their caregivers.

Sentinel Lymph Node Mapping for Uterine Cancer

Gynecologic oncologists at Moffitt Cancer Center are performing sentinel lymph node (SLN) mapping as a less-invasive alternative for uterine cancer...

Clinscience and OncoBay Clinical Partner to Expand Immuno-Oncology Research Globally

The Polish clinical research organization Clinscience made a major investment in OncoBay to partner on projects in the U.S. and Europe

Moffitt Partners with IBA for Proton Therapy

Moffitt partners with (Ion Beam Applications S.A., EURONEXT, to bring proton therapy to patients. This novel technology is impactful when treating...

Ovarian Transposition an Option for Fertility Preservation for Some Cervical Cancer Patients

For young women with cervical cancer, the possibility of losing the ability to have children can be a particularly challenging part of their...

Phase 1 Study Evaluating the Combination of 3 Immunotherapies in Metastatic HER2-Positive Breast Cancer Patients

Moffitt's Breast Oncology team assess a new Phase 1 HER2+ metastatic breast cancer trial combining T cell therapy following HER2-pulsed dendritic...

Knowing When Minimally Invasive Cancer Surgery is the Best Treatment Option Can Saves Lives

It’s vital that cancer surgeons understand when minimally invasive cancer surgery procedures are optimal for their patients and when they are not.

Predicting IPMN Pathology Using Noninvasive Radiogenomics

Dr. Jennifer Permuth is leading a study funded by the National Cancer Institute on early detection and prevention related to intraductal papillary...

Q&A: Dr. Mok Shares His Role as an Advanced Endoscopist

Dr. Shaffer Mok, a gastroenterologist and advanced endoscopist, shares advancements in the treatment of gastrointestinal cancers.

Phase 1 Trial: Evaluating Claudin18.2-Specific CAR T Cells in Gastrointestinal Cancers

A phase 1 clinical trial evaluates the effectiveness of CLDN18.2-targeted CAR-T cells in digestive system cancers.

Identification of Targetable Gene Fusions Present in KRASWT Pancreatic Adenocarcinoma and the Response to Targeted Therapy

Study shows Oncogene fusions are present in KRASWT pancreatic adenocarcinomas at an increased frequency when compared with KRASMUT pancreatic...

A New Approach to Cancer Diagnostics

Moffitt's Diagnostic Imaging and Interventional Radiology Program provides the highest level of diagnosis services resulting in the most effective...

5-ALA is Transforming the Treatment of Glioblastoma

By enhancing a surgeon’s ability to clearly visualize the boundaries of the tumor, 5-ALA-guided tumor resection can provide a tremendous advantage.